REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Deeam Pharmaceutical S.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Secondary Activities: Medicinal and Botanical Manufacturing
Full name: Deeam Pharmaceutical S.A. Profile Updated: June 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Deeam Pharmaceutical S.A. is a company based in Ecuador, with its head office in Guayaquil. The company operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on November 05, 2019. There are currently 2 (2022) people employed by Deeam Pharmaceutical S.A.. The latest financial highlights indicate a net sales revenue drop of 89.9% in 2022. Its’ total assets recorded a negative growth of 67.38%.

Headquarters
Av. Juan Tanca Marengo Solar 02
Guayaquil; Guayas;

Contact Details: Purchase the Deeam Pharmaceutical S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Deeam Pharmaceutical S.A. report to view the information.
Outstanding Shares:
Purchase the Deeam Pharmaceutical S.A. report to view the information.
Registered Capital:
Purchase the Deeam Pharmaceutical S.A. report to view the information.
Incorporation Date:
November 05, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Deeam Pharmaceutical S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-89.9%▼
Total operating revenue
-89.9%▼
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-67.38%▼
Total equity
248.46%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
77.11%▲
Cash Ratio
10.87%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo